Results 131 to 140 of about 11,960 (207)

Drug-drug interaction between dolutegravir and artemether-lumefantrine in HIV and malaria mono- and co-infections: a pharmacogenetic analysis from Ghana. [PDF]

AIDS Res Ther
Thomford NE, Kellermann T, Twum JA, Anyimadu J, Dixon C, Sappor D, Blackhurst D, Barnie PA, Ryabinina O, Nyarko SB, Biney RP, Ekor M, Kyei GB.   +12 more
europepmc   +1 more source

Dose-Optimization of a Novel Co-Formulated Triple Combination Antimalarial Therapy: Artemether-Lumefantrine-Amodiaquine. [PDF]

Clin Pharmacol Ther
Tarning J, White NJ, Dondorp AM.
europepmc   +1 more source

CYP2B6*6 single nucleotide polymorphism among patients with uncomplicated malaria in Adjumani district, Uganda: Implications on efficacy of artemether-lumefantrine. [PDF]

PLoS One
Angwe MK, Mwebaza N, Nsobya SL, Kiguba R, Vudriko P, Dralabu S, Omali D, Tumwebaze MA, Ocan M.   +8 more
europepmc   +1 more source

Therapeutic efficacy of artemether-lumefantrine in North-Eastern states of India and prevalence of drug resistance-associated molecular markers. [PDF]

Malar J
Dutta S, Krishna S, Vishwakarma AK, Mishra S, Khandai S, Goswami D, Kumari S, Ali N, Verma AK, Singh K, Das A, Anvikar AR, Bharti PK.   +12 more
europepmc   +1 more source

Artemether-Lumefantrine Treatment Selects Plasmodium falciparum Multidrug Resistance 1 (pfmdr1) Increased Copy Number Among African Malaria Infections. [PDF]

J Infect Dis
Fançony C, Fortes-Gabriel E, Zage F, Alexiou E, Broumou I, Pernaute-Lau L, Panzo J, António EJ, Cristovão MS, Domingos JM, Sassoma E, Kuatoko F, Rosario EVN, Martins A, Färnert A, Bernardino L, de Sousa TN, Gil JP.   +17 more
europepmc   +1 more source

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022. [PDF]

Malar J
Nhama A, Chidimatembue A, Nhamussua L, Bassat Q, da Silva C, Nhacolo A, Arnaldo P, Salvador C, Cassy A, Candrinho B, Dimene M, Carvalho E, Saifodine A, Wate F, Mucavele H, Torres-Mendoza Y, Horton B, Plucinski M, Cistero P, Mayor A, Aide P.   +20 more
europepmc   +1 more source

Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers. [PDF]

Malar J
Oyebola KM, Ligali FC, Owoloye AJ, Aina OO, Alo YM, Erinwusi B, Olufemi MJ, Salako BL.   +7 more
europepmc   +2 more sources

Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial. [PDF]

Lancet Infect Dis
Kamya MR, Nankabirwa JI, Ebong C, Asua V, Kiggundu M, Orena S, Okitwi M, Tukwasibwe S, Agaba B, Kyabayinze D, Opigo J, Rutazana D, Binagwa B, Mugwanya E, Babirye S, Sebikaari G, Condo PM, Appiah G, Nsobya SL, Conrad MD, Rosenthal PJ, Moriarty LF, Yeka A.   +22 more
europepmc   +1 more source

Therapeutic efficacy and tolerability of artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Niger, 2020. [PDF]

Malar J
Laminou IM, Issa I, Adehossi E, Maman K, Jackou H, Coulibaly E, Tohon ZB, Ahmed J, Sanoussi E, Koko D.   +9 more
europepmc   +1 more source

Effectiveness of artemether-lumefantrine for treating uncomplicated malaria in low- and high-transmission areas of Ghana. [PDF]

Malar J
Mawuli MA, Amoah LE, Cui L, Quashie NB, Afrane YA.   +4 more
europepmc   +1 more source